Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

SARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06936983134897
Basic UDI-DI Code
B-06936983134897
Reference
IRT-545
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The SARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV) and Adenovirus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV/Adenovirus infection in conjunction with clinical presentation and the results of other laboratory tests.

CND Nomenclature Codes

Code Description
W0105070599 MULTIPLE INFECTIOUS - MULTIPLEX ASSAYS - OTHER

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all